With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.1228788-25-7,Pyridazin-3-ylmethanamine hydrochloride,as a common compound, the synthetic route is as follows.
To a solution of 2,3,6-trifluorophenyl acetic acid (5.5 g, 29 mmol) and the intermediate from Step C (5.0 g, 34 mmol) in DCM (20 mL) was added EDC (7.9 g, 41.2 mmol) followed by DIEA (17.99 mL, 103 mmol). After stirring the reaction at room temperature for 18 hours, it was diluted with DCM (100 mL), and washed with water (2X). The organic layer was washed with brine, dried over anhydrous sodium sulfate, filtered and concentrated to give a brown solid. LC3 rt = 0.6 min, m/z = 282 (M+H)., 1228788-25-7
1228788-25-7 Pyridazin-3-ylmethanamine hydrochloride 53419881, apyridazine compound, is more and more widely used in various fields.
Reference£º
Patent; Merck Sharp & Dohme Corp.; BROCKUNIER, Linda, L.; GUO, Jian; PARMEE, Emma, R.; RAGHAVAN, Subharekha; ROSAUER, Keith; STELMACH, John, E.; SCHMIDT, Darby Rye; (87 pag.)EP2373317; (2016); B1;,
Pyridazine – Wikipedia
Pyridazine | C4H4N2 – PubChem